• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌的软组织转移:一例报告

Soft tissue metastasis in colorectal cancer: a case report.

作者信息

Zenzri Yosr, Ghodhbani Zahra, Yacoub Haythem, Houcine Yoldez, Ben Mansour Hajer, Meddeb Khedija, Maamouri Nadia, Mezlini Amel

机构信息

Oncology Department, Salah Azaïez Institute, Tunis, Tunisia.

Faculty of Medicine of Tunis, El Manar University, Tunis, Tunisia.

出版信息

J Med Case Rep. 2025 May 30;19(1):260. doi: 10.1186/s13256-025-05317-9.

DOI:10.1186/s13256-025-05317-9
PMID:40448204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12123813/
Abstract

BACKGROUND

Soft tissue metastases of solid tumors are rare events, especially for colorectal cancers.

CASE PRESENTATION

We report herein the case of a 65-year-old Arab woman with soft tissue metastases (left arm, right scapula, and right axillary masses) of a colorectal cancer 4 years after the initial surgery. The patient was treated with folinic acid-fluorouracil-irinotecan and bevacizumab as first-line treatment. One year after completion of chemotherapy, the patient remained alive.

CONCLUSIONS

The key aim in reporting this case is to raise awareness among oncologists regarding potential unusual metastasis locations of colon adenocarcinoma such as skin and skeletal muscle.

摘要

背景

实体瘤的软组织转移较为罕见,尤其是结直肠癌。

病例报告

我们在此报告一例65岁阿拉伯女性病例,其在初次手术后4年出现结直肠癌的软组织转移(左臂、右肩胛骨和右腋窝肿块)。该患者接受亚叶酸钙-氟尿嘧啶-伊立替康和贝伐单抗作为一线治疗。化疗完成一年后,患者仍然存活。

结论

报告此病例的关键目的是提高肿瘤学家对结肠腺癌潜在不寻常转移部位(如皮肤和骨骼肌)的认识。

相似文献

1
Soft tissue metastasis in colorectal cancer: a case report.结直肠癌的软组织转移:一例报告
J Med Case Rep. 2025 May 30;19(1):260. doi: 10.1186/s13256-025-05317-9.
2
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.改良 XELIRI(卡培他滨联合伊立替康)对比 FOLFIRI(亚叶酸钙、氟尿嘧啶、伊立替康),二者均联合或不联合贝伐珠单抗,作为转移性结直肠癌的二线治疗(AXEPT):一项多中心、开放标签、随机、非劣效性、3 期临床试验。
Lancet Oncol. 2018 May;19(5):660-671. doi: 10.1016/S1470-2045(18)30140-2. Epub 2018 Mar 16.
3
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial.KRAS 野生型转移性结直肠癌一线进展后继续贝伐珠单抗或西妥昔单抗联合化疗:UNICANCER PRODIGE18 随机临床试验
JAMA Oncol. 2019 Jan 1;5(1):83-90. doi: 10.1001/jamaoncol.2018.4465.
4
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial.初治不可切除结直肠癌肝转移的一线全身治疗:CAIRO5随机临床试验的事后分析
JAMA Oncol. 2025 Jan 1;11(1):36-45. doi: 10.1001/jamaoncol.2024.5174.
5
Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancer.亚叶酸、5-氟尿嘧啶和伊立替康(FOLFIRI)二线治疗联合帕尼单抗和贝伐单抗用于转移性结直肠癌患者的安全性和有效性。
Med Oncol. 2014 Jul;31(7):35. doi: 10.1007/s12032-014-0035-3. Epub 2014 Jun 12.
6
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial.贝伐珠单抗联合 mFOLFOX-6 或 FOLFOXIRI 方案治疗初治不可切除的结直肠癌肝转移患者:OLIVIA 多中心随机 II 期临床试验。
Ann Oncol. 2015 Apr;26(4):702-708. doi: 10.1093/annonc/mdu580. Epub 2014 Dec 23.
7
Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.随机对照试验研究伊立替康载药微球联合 FOLFOX 和贝伐珠单抗治疗不可切除结直肠癌肝转移患者
Cancer. 2015 Oct 15;121(20):3649-58. doi: 10.1002/cncr.29534. Epub 2015 Jul 6.
8
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study.贝伐珠单抗联合或不联合阿替利珠单抗用于转移性结直肠癌患者的 upfront 氟尿嘧啶、亚叶酸钙、奥沙利铂和伊立替康:ATEZOTRIBE 研究的更新和总生存结果。
J Clin Oncol. 2024 Aug 1;42(22):2637-2644. doi: 10.1200/JCO.23.02728. Epub 2024 Jun 12.
9
FOLFIRI combined with bevacizumab as first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia after UGT1A1 genotyping.在进行UGT1A1基因分型后,FOLFIRI联合贝伐单抗作为伴有高胆红素血症的转移性结直肠癌患者的一线治疗方案。
Med Princ Pract. 2014;23(5):478-81. doi: 10.1159/000358799. Epub 2014 Mar 8.
10
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial. upfront FOLFOXIRI 联合贝伐珠单抗和进展后再引入与 mFOLFOX6 联合贝伐珠单抗后序贯 FOLFIRI 联合贝伐珠单抗治疗转移性结直肠癌患者(TRIBE2):一项多中心、开放标签、3 期、随机、对照临床试验。
Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9.

本文引用的文献

1
Skeletal muscle metastasis with bone metaplasia from colon cancer: A case report and review of the literature.结肠癌伴骨化生的骨骼肌转移:一例报告及文献复习
World J Clin Cases. 2021 Oct 26;9(30):9285-9294. doi: 10.12998/wjcc.v9.i30.9285.
2
Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes.结直肠癌流行病学:近期趋势及其对结局的影响。
Curr Drug Targets. 2021;22(9):998-1009. doi: 10.2174/1389450121999201117115717.
3
Metastases to soft tissue: a review of 118 cases over a 30-year period.软组织转移:30年期间118例病例回顾
Cancer. 2008 Jan 1;112(1):193-203. doi: 10.1002/cncr.23151.
4
Metastasis to the forearm skeletal muscle from an adenocarcinoma of the colon: report of a case.
Surg Today. 2000;30(12):1118-23. doi: 10.1007/s005950070013.
5
Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature.远处软组织转移:30例新患者及文献报道的91例病例系列。
Ann Surg Oncol. 2000 Aug;7(7):526-34. doi: 10.1007/s10434-000-0526-7.
6
Metastatic carcinoma to skeletal muscle. A report of 15 patients.转移性癌累及骨骼肌。15例病例报告。
Clin Orthop Relat Res. 1998 Oct(355):272-81. doi: 10.1097/00003086-199810000-00029.
7
Gastric carcinoma metastasis to calf muscles: MR findings.
Radiat Med. 1996 Jan-Feb;14(1):35-6.
8
CT detection of skeletal muscle metastases.
J Comput Assist Tomogr. 1986 Jan-Feb;10(1):81-3. doi: 10.1097/00004728-198601000-00018.
9
Metastatic adenocarcinoma of the paraspinal muscles.
Br J Radiol. 1988 Sep;61(729):849-51. doi: 10.1259/0007-1285-61-729-849.
10
Needle aspiration biopsy: a critical appraisal. Eight years and 3,267 specimens later.
JAMA. 1978 Jan 2;239(1):36-9.